Formosa Pharmaceuticals, Inc.
3 clinical trials · Sponsor
◉ Watch Formosa Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study (NCT04810962) | Formosa Pharmaceuticals, Inc. | 2021-03-16 |
| Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery (NCT04739709) | Formosa Pharmaceuticals, Inc. | 2021-01-11 |
| A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery (NCT04089735) | Formosa Pharmaceuticals, Inc. | 2019-08-13 |
Track Formosa Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.